From the first launch to ongoing market access operational execution, IntegriChain solves some of the most complex and pressing challenges associated with drug commercialization. We deliver pharma’s only comprehensive data, consulting, and business process platform for market access departments, providing the strategy, data, applications, and infrastructure for therapy commercialization.
Solutions overview
IntegriChain delivers the pharmaceutical industry’s largest and only data and business process platform for therapy commercialization and access. Manufacturers rely on our analytics, applications, and managed services to power their operations and harness the value of their channel, patient and payer data.
View all products
IntegriChain provides a complete set of professional services for commercialization and market access execution–from life science strategy and operational consulting to implementation, integration, migrations, and analytics.
Services overview
We help all stakeholders in the pharmaceutical industry drive access with our relentless focus on unifying all of the critical business functions for therapy commercialization and access – contracts & pricing, gross-to-net, channel, and patient services – to unlock strategic payer, provider, pharmacy and patient access insights.
Learn more about our company
Learn more about joining our growing IntegriChain team of data scientists, market access experts, analysts, and consulting professionals – our culture, our purpose, our teams in the US and Pune. Check out our careers or keep in touch for future opportunities.
Careers overview
October 28, 2019
Philadelphia, PA, October 28, 2019– IntegriChain, a leading life sciences commercial data and analytics company that helps patients start therapy faster and stay on therapy longer, today announced that the Company has been named to the Philadelphia100 list of fastest growing, privately held entrepreneurial companies. IntegriChain placed 29th on the Philadelphia100 list in an awards ceremony last week.
“We are proud to be named to the Philadelphia100 list and share this recognition with our entire team of outstanding data scientists and professionals who work tirelessly every day to realize our mission to save patient days of therapy,” said IntegriChain CEO Kevin Leininger. “We have rapidly grown over the last three years through the organic buildout of our SaaS platform as well as through strategic acquisitions, and today we serve the data and analytics needs of more than 175 leading Life Sciences manufacturers – from Big Pharma to emerging innovators. We have built a world-class platform for the Life Sciences industry right here in Center City, and we are honored to be part of Greater Philadelphia’s business and data tech communities.”
The Philadelphia100® has been the hallmark of entrepreneurial achievement in the region since 1988. Cofounded by the Entrepreneurs’ Forum of Greater Philadelphia to celebrate the success of both its CEO members and local CEOs, the Philadelphia100® awards identifies and honors the 100 fastest growing, privately held entrepreneurial companies in the Greater Philadelphia Region. What started as an idea to bring recognition to our region has emerged as a new standard – a standard of excellence. The Philadelphia100 is a merit-based program.
Only companies that are among the fastest growing, privately held companies are awarded the Philadelphia10 designation. The integrity of the process and the resulting list makes the Philadelphia100® one of the most sought-after awards in the region. The Philadelphia100 winners are celebrated at an awards program among 500 leaders and acknowledged in a special section of the Philadelphia Inquirer reaching nearly 1 million readers.
About IntegriChain IntegriChain is a life sciences commercial data and analytics company that helps innovative bio/pharma manufacturers identify and remove barriers to patient therapy initiation and adherence. Our mission is to help all stakeholders in pharmaceutical access save as many patient days of therapy as possible. Our data-science-driven ICyte Platform and solutions uniquely focus on access challenges after the patient and provider commit to therapy. More than 165 life science manufacturers rely on insights delivered from IntegriChain’s data, analytics, and managed services to drive strategic decision-making and on-going business management across their payers, specialty pharmacies, patient services, and distribution channel partners. IntegriChain is backed by Accel-KKR, a leading Silicon Valley technology private equity firm. The company is headquartered in Philadelphia, PA, with offices in Ambler, PA; Somerset, NJ, and Pune, India. For more information, visit www.integrichain.com and our blog, or follow us on Twitter @IntegriChain and LinkedIn.
Contact Jennifer Guinan | Sage Strategic Marketing | 610.410.8111 | Jennifer@sagestrat.com
Register Now
Webinars & Resources
See List
